文献速递胸部肿瘤

MAGRIT试验:NSCLC术后强化随访对复发检测与生存的影响

Effectiveness of intensive clinical and radiological follow-up in patients with surgically resected NSCLC. Analysis of 2661 patients from the prospective MAGRIT trial.
PubMed 文献 · Eur J Cancer · 2019-12-13

基于MAGRIT III期随机对照试验中2261例手术切除的IB-IIIA期NSCLC患者数据,分析强化临床与影像学随访对复发检测模式及生存的影响。结果显示,计划性随访主要检测局部区域复发(88.4%)和新原发肺癌(93.2%),而远处转移仅68.7%通过计划随访发现;计划随访检出的局部复发或新原发肺癌患者生存显著优于非计划检出者(HR 0.56)。

要点

  • 强化随访可有效检出局部区域复发和新原发肺癌,并改善其生存。
  • 远处转移多数通过非计划检查发现,强化随访对其检出影响有限。
  • 术后18个月内复发风险最高,6-12个月达峰值。

核心结论

  • 强化随访能有效检测局部区域复发和第二原发肺癌,并影响患者生存,但未能影响远处转移的检测。

研究设计与样本

  • MAGRIT是一项III期辅助随机对照试验,纳入手术切除的IB-IIIA期NSCLC患者,所有参与者均接受前瞻性定义的强化临床与影像学随访;本研究在患者水平分析了2261例患者的数据。

主要发现

  • 88.4%(95% CI 84%-91%)的局部区域复发和93.2%(95% CI 84%-99%)的新原发肺癌通过计划检查检出,而远处转移仅68.7%(95% CI 65%-73%)通过计划检查检出(p < 0.001)。
  • 计划检查检出的局部区域复发或新原发肺癌患者生存显著优于非计划检查检出者(HR 0.56,95% CI 0.36-0.87;p = 0.01)。
  • 远处复发患者无论计划或非计划检出,生存均较差(复发后3年生存率分别为22.0%和21.8%)。
  • 复发率在术后前18个月内最高,6至12个月达峰值,之后下降;第二原发肺癌的风险随时间保持恒定。

临床怎么用

  • 对于手术切除的早期NSCLC患者,强化临床与影像学随访有助于检出局部区域复发和新原发肺癌,可能改善生存。
  • 远处转移的检出可能更多依赖非计划检查,随访策略需关注远处转移的监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Limited evidence is available on effectiveness of clinicoradiological follow-up of early-stage NSCLC patients. MAGRIT was a phase III adjuvant RCT conducted in surgically resected stage IB-IIIA NSCLC patients, in which all participants had a prospectively defined intensive clinicoradiological follow-up. METHODS: At patient-level data, we analyzed detection modality of disease recurrences and new primary lung cancer (i.e. detected by clinicoradiological scheduled exams versus by interim unscheduled exams), features associated with higher risk of locoregional and/or distant recurrence, and recurrence rates over time. RESULTS: In the 2261 patients studied, there was a significant association between the type of recurrence and the modality of detection: 88.4% (95% CI, 84%-91%) of the locoregional recurrences and 93.2% (95% CI, 84%-99%) of the new primary lung cancers were detected by scheduled exams, whereas this was only 68.7% (95% CI, 65%-73%) for distant metastases (p < 0.001). Survival of patients with locoregional recurrence or new primary lung cancer detected by scheduled exams was significantly better as compared with those detected by unscheduled exams (HR 0.56, 95% CI 0.36-0.87; p = 0.01). Survival was similarly poor in patients with distant recurrences, both with scheduled and unscheduled detection (3-year survival after recurrence 22.0% and 21.8%, respectively). Recurrence rate was the highest in the first 18 months after surgery-with a peak between month 6 and 12-decreasing thereafter. The hazard of a second primary lung cancer was constant over time. CONCLUSION: Intensive follow-up is effective in detecting locoregional recurrences and second primary lung cancers, with impact on patients' survival but did not influence the detection of distant recurrences.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Conforti F, Pala L, Pagan E, et al. Effectiveness of intensive clinical and radiological follow-up in patients with surgically resected NSCLC. Analysis of 2661 patients from the prospective MAGRIT trial. Eur J Cancer. 2019. PMID: 31841793. doi:10.1016/j.ejca.2019.11.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。